There are 2 versions of this bill. View text

Click the check-box to add or remove the section, click the text link to scroll to that section.
Titles Actions Overview All Actions Cosponsors Committees Related Bills Subjects Latest Summary All Summaries

Titles (1)

Official Titles

Official Titles - House of Representatives

Official Title as Introduced

To amend the Federal Food, Drug, and Cosmetic Act, with respect to eligibility for approval of a subsequent generic drug, to remove the barrier to that approval posed by the 180-day exclusivity period afforded to a first generic applicant that has not yet received final approval, and for other purposes.


Actions Overview (2)

Date Actions Overview
05/02/2019Reported by the Committee on Energy and Commerce. H. Rept. 116-46.
01/31/2019Introduced in House

All Actions (9)

Date All Actions
05/02/2019Placed on the Union Calendar, Calendar No. 24.
Action By: House of Representatives
05/02/2019Reported by the Committee on Energy and Commerce. H. Rept. 116-46.
04/03/2019Ordered to be Reported by Voice Vote.
Action By: Committee on Energy and Commerce
04/03/2019Committee Consideration and Mark-up Session Held.
Action By: Committee on Energy and Commerce
03/27/2019Forwarded by Subcommittee to Full Committee by Voice Vote .
Action By: House Energy and Commerce Subcommittee on Health
03/27/2019Subcommittee Consideration and Mark-up Session Held.
Action By: House Energy and Commerce Subcommittee on Health
02/02/2019Referred to the Subcommittee on Health.
Action By: Committee on Energy and Commerce
01/31/2019Referred to the House Committee on Energy and Commerce.
Action By: House of Representatives
01/31/2019Introduced in House
Action By: House of Representatives

Cosponsors (16)


Committees (1)

Committees, subcommittees and links to reports associated with this bill are listed here, as well as the nature and date of committee activity and Congressional report number.

Committee / Subcommittee Date Activity Reports
House Energy and Commerce01/31/2019 Referred to
04/03/2019 Markup by
05/02/2019 Reported by H. Rept. 116-46
House Energy and Commerce Subcommittee on Health02/02/2019 Referred to
03/27/2019 Markup by
03/27/2019 Reported by

A related bill may be a companion measure, an identical bill, a procedurally-related measure, or one with text similarities. Bill relationships are identified by the House, the Senate, or CRS, and refer only to same-congress measures.


Latest Summary (0)

A summary is in progress.